Caricamento...
Polysaccharide Nanoparticles Can Efficiently Modulate the Immune Response against an HIV Peptide Antigen
[Image: see text] The development of an effective HIV vaccine continues to be a major health challenge since, so far, only the RV144 trial has demonstrated a modest clinical efficacy. Recently, the targeting of the 12 highly conserved protease cleavage sites (PCS1–12) has been presented as a strateg...
Salvato in:
| Pubblicato in: | ACS Nano |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American
Chemical Society
2019
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6607401/ https://ncbi.nlm.nih.gov/pubmed/30964270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsnano.8b07662 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|